市場調査レポート

商品コード

1561032

ジェネリック薬の市場規模、シェア、成長分析、タイプ別、ブランド別、適応症別、投与経路別、流通チャネル別、地域別 - 産業予測、2024年～2031年

Generic Drugs Market Size, Share, Growth Analysis, By Type, By Brand, By Indication, By Route of Administration, By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日: 2024年09月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 805,335円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 942,090円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,078,845円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=151.95円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ジェネリック薬の世界市場規模は2022年に4,074億米ドルと評価され、2023年の4,235億米ドルから2031年には5,707億米ドルに成長し、予測期間中（2024年～2031年）のCAGRは3.8%で成長する見通しです。

ジェネリック薬の世界市場は、ブランド薬の特許切れ、ヘルスケアコストの上昇、手頃な価格の治療オプションの需要など、いくつかの重要な要因に後押しされ、近年著しい成長を遂げています。ジェネリック薬の利用可能性は、多くのブロックバスター医薬品の特許保護が終了したことにより、ジェネリックメーカーが市場に参入し、競争が激化したことにより強化されました。この競争によって薬価が下がり、患者にとって必要不可欠な医薬品へのアクセスが向上しています。心血管疾患、糖尿病、がんなどの慢性疾患の増加は、費用対効果の高い治療へのニーズをさらに高め、ジェネリック薬の魅力を高めています。さらに、さまざまな政府やヘルスケアシステムがジェネリック薬の使用を支援する政策を導入し、特に新興市場において医療費の削減と医薬品へのアクセスの向上を目指しています。承認プロセスを合理化し、規制の枠組みを改善する取り組みも市場拡大に寄与しています。その成長にもかかわらず、ジェネリック薬市場はいくつかの課題に直面しています。ジェネリック薬の承認プロセスは、国によって規制状況が異なり複雑であるため、先発医薬品との生物学的同等性を証明する必要があり、研究開発に多額の投資が必要となります。知的財産の問題や、ジェネリック薬企業と先発医薬品企業間の法的紛争も、市場参入の障壁となる可能性があります。さらに、厳格な試験や安全基準の遵守にもかかわらず、ジェネリック薬の品質や有効性には懸念があります。より広く受け入れられるためには、患者やヘルスケア提供者の間で信頼を築くことが不可欠です。さらに、多くの企業が市場シェアを争う競合市場であるため、利益率が圧迫され、競争力を維持するために研究開発、流通への継続的な投資が必要となります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Teva Pharmaceuticals Industries Ltd.,（Israel）
Novartis AG,（Switzerland）
Pfizer Inc.,（US）
Sun Pharmaceutical Industries Ltd.,（India）
Fresenius SE & Co. KGaA.（Germany）
Lupin（India）
Endo International plc.,（Ireland）
Aurobindo Pharma（India）
Novartis AG（Switzerland）
Hikma Pharmaceuticals PLC.（UK）
STADA Arzneimittel AG（Germany）
Eli Lilly and Company（US）
Aspen Holdings（South Africa）
Dr. Reddy's Laboratories Ltd.（India）
Zydus Cadila（India）
Amgen Inc.（US）
Boehringer Ingelheim（Germany）
Baxter International Inc.（US）
MediGene AG（Germany）
Alvogen（US）
Sandoz International GmbH（Switzerland）
Bristol-Myers Squibb Company（US）
Recordati Industria Chimica e Farmaceutica S.p.A.（Italy）

Product Code: SQMIG35J2094

Global Generic Drugs Market size was valued at USD 407.4 Billion in 2022 and is poised to grow from USD 423.5 Billion in 2023 to USD 570.7 Billion by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).

The global market for generic drugs has seen remarkable growth in recent years, fueled by several key factors including the expiration of patents for branded drugs, rising healthcare costs, and the demand for affordable treatment options. The availability of generic drugs has been bolstered by the end of patent protections for many blockbuster medications, which has allowed generic manufacturers to enter the market and increase competition. This competition has led to reduced drug prices and better access to essential medicines for patients. The growing prevalence of chronic conditions such as cardiovascular diseases, diabetes, and cancer has further driven the need for cost-effective treatments, enhancing the appeal of generic drugs. Additionally, various governments and healthcare systems have introduced policies to support the use of generics, aiming to lower healthcare costs and improve medication accessibility, particularly in emerging markets. The efforts to streamline the approval process and refine regulatory frameworks have also contributed to market expansion. Despite its growth, the generic drugs market faces several challenges. A complex and varying regulatory landscape across countries can complicate the approval process for generics, which requires proving bioequivalence to brand-name drugs-a task that demands significant investment in research and development. Intellectual property issues and legal disputes between generic and brand-name companies can also create barriers to market entry. Additionally, there are concerns about the perceived quality and efficacy of generic drugs, despite rigorous testing and compliance with safety standards. Building trust among patients and healthcare providers is essential for wider acceptance. Furthermore, the competitive nature of the market, with numerous players striving for market share, puts pressure on profit margins and necessitates ongoing investment in research, development, and distribution to stay competitive.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Generic Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Generic Drugs Market Segmental Analysis

Global Generic Drugs Market is segmented Type, Brand, Indication, Route of Administration, End-Users, Distribution Channel, and region. Based on Type, the market is segmented into Simple Generics, and Super Generics. Based on Brand, the market is segmented into Pure Generic, and Branded Generic. Based on Indication, the market is segmented into Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, and Respiratory Others. Based on Route of Administration, the market is segmented into Oral, Topical, Parenteral, and Others. Based on End-Users, the market is segmented into Hospitals, Homecare, Specialty Clinics, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Generic Drugs Market

The increasing global prevalence of chronic diseases, including cardiovascular disorders, diabetes, respiratory conditions, and cancer, is fueling the demand for generic drugs. These cost-effective alternatives offer an affordable way to manage and treat these persistent health issues. As more individuals seek budget-friendly options for long-term treatment, the role of generic drugs in addressing these conditions becomes more prominent. The growing incidence of these chronic illnesses highlights the need for accessible and economical treatment solutions. Generic drugs are well-positioned to meet this demand, providing effective therapies at a lower cost compared to their branded counterparts. This shift towards affordable treatment options is a significant driver behind the rising popularity and market growth of generic drugs.

Restraints in the Global Generic Drugs Market

The generic drugs market is characterized by a complex and rigorous regulatory environment. Manufacturers must navigate detailed approval procedures, including proving bioequivalence to brand-name medications. These stringent requirements can delay the introduction of generic drugs to the market and lead to higher costs for producers. The challenges associated with regulatory compliance can significantly impact the speed and expense of bringing generic drugs to market. The need to meet comprehensive standards and demonstrate that generic drugs perform identically to their branded counterparts can create hurdles for manufacturers, affecting their ability to efficiently compete and innovate.

Market Trends of the Global Generic Drugs Market

The market has seen a growing trend of consolidation, where larger pharmaceutical companies are acquiring smaller generic drug manufacturers or entering into strategic partnerships. This consolidation strategy is designed to broaden product offerings, boost manufacturing capabilities, and extend market reach. By merging with or acquiring smaller firms, major pharmaceutical companies aim to strengthen their market position and streamline operations. These moves help them to integrate new technologies, enhance production efficiency, and access a wider range of generic drug products, ultimately improving their competitive edge in the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Generic Drugs Market by Type

Market Overview
Simple Generics
Super Generics

Generic Drugs Market by Brand

Market Overview
Pure Generic
Branded Generic

Generic Drugs Market by Indication

Market Overview
Central Nervous System (CNS)
Cardiovascular
Dermatology
Oncology
Respiratory
Others

Generic Drugs Market by Route of Administration

Market Overview
Oral
Topical
Parenteral
Others

Generic Drugs Market by End-Users

Market Overview
Hospitals
Homecare
Specialty Clinics
Others

Generic Drugs Market by Distribution Channel

Market Overview
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Generic Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Teva Pharmaceuticals Industries Ltd., (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG, (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc., (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd., (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International plc., (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STADA Arzneimittel AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Holdings (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Cadila (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MediGene AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alvogen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz International GmbH (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recordati Industria Chimica e Farmaceutica S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ジェネリック薬の市場規模、シェア、成長分析、タイプ別、ブランド別、適応症別、投与経路別、流通チャネル別、地域別 - 産業予測、2024年～2031年

Generic Drugs Market Size, Share, Growth Analysis, By Type, By Brand, By Indication, By Route of Administration, By Distribution Channel, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ジェネリック薬市場：タイプ別

ジェネリック薬市場：ブランド別

ジェネリック薬市場：適応症別

ジェネリック薬市場：投与経路別

ジェネリック薬市場：エンドユーザー別

ジェネリック薬市場：流通チャネル別

ジェネリック薬市場：地域別規模